Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 169,180 | N/A | N/A |
| Marketable Securities | N/A | N/A | 441,390 | N/A | N/A |
| Receivables | N/A | N/A | 914,500 | N/A | N/A |
| Inventories | N/A | N/A | 408,910 | N/A | N/A |
| TOTAL | $N/A | $N/A | $1,933,980 | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 38,210 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 38,670 | 0 | 0 |
| TOTAL | $N/A | $N/A | $76,880 | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $3,868,120 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 87,460 | 0 | 0 |
| Other current liabilities | N/A | N/A | 426,430 | N/A | N/A |
| TOTAL | $N/A | $N/A | $800,300 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 265,550 | N/A | N/A |
| aiOther Non-Current Liabilities | 0 | 0 | 73,700 | 0 | 0 |
| TOTAL | $N/A | $N/A | $339,250 | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $1,139,570 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 113,290 | N/A | N/A |
| Retained earnings | N/A | N/A | 2,197,580 | N/A | N/A |
| Other shareholders' equity | 0 | 0 | 34,150 | 0 | 0 |
| TOTAL | $N/A | $N/A | $2,728,550 | $N/A | $N/A |
| Total Liabilities And Equity | $0 | $0 | $3,868,120 | $0 | $0 |